Caranx Medical Surgical AI Platform
AI-powered surgical guidance and robotics platform
Company profile
Company profile
Caranx Medical is a company operating in the surgical AI and robotics sector, developing advanced technology solutions designed to enhance surgical procedures and patient outcomes. The company focuses on creating innovative platforms that integrate artificial intelligence and robotic systems to support surgeons and healthcare providers in delivering more precise, efficient, and effective surgical care. While specific product details are limited from the available information, Caranx Medical positions itself within the rapidly evolving field of computer-assisted surgery and intelligent surgical systems. The company's work aligns with broader industry trends toward minimally invasive procedures, real-time surgical guidance, and data-driven clinical decision support. Caranx Medical serves healthcare providers, surgical teams, and hospital systems seeking to adopt next-generation surgical technologies that can improve procedural accuracy, reduce complications, and optimize patient recovery times.
Company description Caranx Medical official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Other deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered surgical guidance and robotics platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Computer assisted surgery (Abingdon, England) · Dec 1, 2026
TBDM: Temporal boundary distillation module for surgical gesture segmentation.International journal of computer assisted radiology and surgery · Aug 28, 2026
Correction: A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.Scientific reports · Jul 15, 2026
A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.Scientific reports · Oct 7, 2025
Optimizing intraoperative AI: evaluation of YOLOv8 for real-time recognition of robotic and laparoscopic instruments.Journal of robotic surgery · Mar 31, 2025
Towards autonomous robot-assisted transcatheter heart valve implantation: in vivo teleoperation and phantom validation of AI-guided positioning.Frontiers in robotics and AI · Jan 1, 2025
Clinical validation
NCT07152574 · Sponsor · NOT YET RECRUITING
Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in AustraliaNCT07121907 · Sponsor · NOT YET RECRUITING
Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI)NCT07100340 · Sponsor · NOT YET RECRUITING
First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance SoftwareNCT07043075 · Sponsor · NOT YET RECRUITING
Regulatory
K243884 · 510k · Jul 7, 2025
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Caranx Medical's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.